Macromolecules
Article
an ethanol−water mixture, dried in vacuum at 80 °C, and further
purified by sublimation to give 6.94 g (yield: 76.9%) of yellow crystals.
Mp: 253 °C. 1H NMR (300 MHz, DMSO-d6): δ 5.10 (H-9, s, 6H), 5.44
(H-1, s, 2H), 6.63−6.65 (H-3, d, J = 4.2 Hz, 2H), 6.73−6.75 (H-8, d, J =
3.9 Hz, 2H), 6.84 (H-6, s, 2H), 7.18−7.20 (H-4, t, J = 3.9 Hz, 2H), 7.25−
7.26 (H-7, d, J = 3.9 Hz, 2H), 7.36−7.38 (H-2, H-5, m, 4H). 13C NMR
(300 MHz, DMSO-d6): δ 64.3, 111.0, 112.2, 114.8, 117.6, 121.2, 123.1,
125.0, 126.4, 126.7, 129.1, 129.8, 141.6, 149.4, 164.6. FTIR (powder, ν,
cm−1): 3426, 3395, 3316, 3211 (N−H stretching), 1630, 1593 (cyclic
CN/CC stretching), 1480, 1464 (skeletal vibrations in conjugated
phenyl/benzoxazole ring), 1255 (Ar−C−O asymmetric stretching).
Anal. Calcd for C13H11N3O: C, 69.32; H, 4.92; N, 18.66. Found: C,
67.82; H, 4.96; N, 18.59.
(p-BOA). Obviously, the para-connecting p-BFO and p-BOA are
isomers of meta-connecting m-BFO and m-BOA, respectively.
The molecular packing and properties including single gas
permeability for the resulting four rigid poly(benzoxazole-co-
imide)s shown in Scheme 2 were investigated. The influence of
polymer structural isomerism on molecular packing and
properties were identified. Systematic investigations and analyses
provide a useful framework for designing modified polyimides to
meet the requirements in commercial membrane-based gas
separations such as desirable permeability, excellent mechanical
and thermal stability etc.
Synthesis of Poly(benzoxazole-co-imide)s. Poly(benzoxazole-
co-imide)s were prepared by using dianhydride with four benzoxazole-
containing diamines, p-BFO, m-BFO, p-BOA, and m-BOA as raw
materials via a two-step azeotropic imidization process, as shown in
Scheme 2. Using the preparation of 6FDA-p-BFO (PIa) as an example,
in a four-necked flask, p-BFO (1.7054 g, 30.0 mmol) was dissolved in
NMP (28 mL), and then 6FDA (1.3327 g, 30.0 mmol) was added. After
the mixture was stirred at room temperature for more than 12 h, 6 mL of
toluene as an azeotropic agent was added to the reaction solution, and
the solution mixture was then heated under reflux for at least 12 h under
a N2 atmosphere. While the toluene was refluxing, water was removed
using a Dean−Stark trap. The resulting brownish solution was poured
into a mixture of water and methanol (1 L, v/v = 1:1) under vigorous
stirring. The resulting fibrous precipitate was filtered off, washed with
cold water, methanol, and dried at 120 °C in a vacuum oven to yield the
6FDA-p-BFO (PIa) white fibrous powder.
EXPERIMENTAL SECTION
■
Materials. 2,4-Diaminophenol dihydrochloride (98.0%), 4-amino-
benzoic acid (>98.0%), 3-aminobenzoic acid (>98.0%), polyphosphoric
acid (PPA, 115%), tin(II) chloride dihydrate (98.0%), toluene (99.8%),
and N-methyl-2-pyrrolidinone (NMP, >99.0%) were purchased from
Sigma-Aldrich Chemical Co. (Milwaukee, WI) and used as received.
4,4′-(Hexafluoroisopropylidene) diphthalic anhydride (6FDA) was
obtained from Sigma-Aldrich Chemical Co. and purified by sublimation
before use. 2,2′-Bis(3-amine-4-hydroxyphenyl)hexafluoropropane
(APAF) was purchased from Central Glass Co. Ltd. (Tokyo, Japan)
and was purified by sublimation before use. Sodium carbonate (>99.0%)
was purchased from Tokyo Chemical Industry (Tokyo, Japan). 5-
Amino-2-(4-aminobenzene)benzoxazole (p-BOA) was obtained from
Changzhou Sunlight Medical Raw Material Co. Ltd. (Jiangsu, China)
and was used as received.
Synthesis of 2,2′-Bis[2-(4-aminophenyl)benzoxazol-6-yl]-
hexafluoropropane (p-BFO). Under a nitrogen atmosphere, PPA
(70.00 g) was added to a three-necked flask, and 4-aminobenzoic acid
(5.80 g, 42.3 mmol), APAF (7.33 g, 20.0 mmol), and tin(II) chloride
dihydrate (0.40 g, 1.8 mmol) were added. The mixture was heated to
110 °C with stirring overnight, and then the resulting solution was
heated to 195 °C and maintained at that temperature for more than 7 h.
After cooling to room temperature, the resulting reaction mixture was
neutralized with 10% sodium carbonate solution. The precipitate was
filtered off, rinsed with distilled water many times, recrystallized in an
ethanol−water mixture, and dried in vacuum at 80 °C to give 9.30 g
(yield: 81.9%) of white needle crystals. Melting point (Mp): 256 °C. 1H
NMR (300 MHz, DMSO-d6): δ 6.10 (H-1, s, 4H), 6.69−6.70 (H-2, d, J
= 4.5 Hz, 4H), 7.24−7.25 (H-5, d, J = 4.5 Hz, 2H), 7.62 (H-4, s, 2H),
7.74−7.75 (H-6, d, J = 4.5 Hz, 2H), 7.85−7.87 (H-3, d, J = 4.5, 4H). 13C
NMR (300 MHz, DMSO-d6): δ 64.1, 110.1, 112.1, 113.5, 120.1, 121.3,
123.2, 125.0, 125.5, 128.7, 129.3, 142.2, 149.9, 152.8, 165.1. FTIR
(powder, ν, cm−1): 3475, 3337, 3216 (N−H stretching), 1630, 1606
(cyclic CN/CC stretching), 1497, 1483 (skeletal vibrations in
conjugated phenyl/benzoxazole ring), 1251 (Ar−C−O asymmetric
stretching). Anal. Calcd for C29H18N4O2F6: C, 61.27; H, 3.19; N, 9.86.
Found: C, 60.98; H, 3.37; N, 10.07.
Synthesis of 2,2′-Bis[2-(3-aminophenyl)benzoxazol-6-yl]-
hexafluoropropane (m-BFO). The synthetic procedure was similar
to that used for diamine p-BFO except that 3-aminobenzoic acid was
used as raw material. White needle-like crystals with a yield of 86.5%
were obtained. Mp: 112 °C. 1H NMR (300 MHz, DMSO-d6): δ 5.54 (H-
1, s, 4H), 6.81−6.83 (H-3, d, J = 5.4 Hz, 2H), 7.23−7.26 (t, H-4, J = 3.9
Hz, 2H), 7.33−7.36 (H-7, H-8, t, J = 4.5 Hz, 4H), 7.43 (H-6, s, 2H), 7.77
(H-2, s, 2H), 7.86−7.88 (H-5, d, J = 4.5 Hz, 2H). 13C NMR (300 MHz,
DMSO-d6): δ 64.3, 111.0, 112.2, 114.8, 117.7, 121.2, 123.1, 125.0, 126.4,
126.7, 129.1, 129.8, 141.7, 149.5, 150.1, 164.5. FTIR (powder, ν, cm−1):
3452, 3354, 3226 (N−H stretching), 1623, 1593 (cyclic CN/CC
stretching), 1493, 1480 (skeletal vibrations in conjugated phenyl/
benzoxazole ring), 1252 (Ar−C−O asymmetric stretching). Anal. Calcd
for C29H18N4O2F6: C, 61.27; H, 3.19; N, 9.86. Found: C, 60.87; H, 3.36;
N, 10.02.
6FDA-p-BFO (PIa). ATR-FTIR (membrane, ν, cm−1): 1787 (imide
CO symmetric stretching), 1724 (imide CO asymmetric
stretching), 1623, 1608 (cyclic CN/CC stretching), 1503, 1479
(skeletal vibrations in conjugated phenyl/benzoxazole ring), 1362
(imide −C-N), 1249 (Ar−C−O asymmetric stretching). Molecular
weight: Mw = 64 × 103 with a polydispersity of 2.2. Anal. Calcd for
C48H20F12N4O6: C, 59.03; H, 2.06; N, 5.74. Found: C, 58.19; H, 2.18; N,
5.70.
6FDA-m-BFO (PIb). ATR-FTIR (membrane, ν, cm−1): 1786 (imide
CO symmetric stretching), 1723 (imide CO asymmetric
stretching), 1625, 1608 (cyclic CN/CC stretching), 1492, 1477
(skeletal vibrations in conjugated phenyl/benzoxazole ring), 1367
(imide −C−N), 1249 cm−1 (Ar−C−O asymmetric stretching).
Molecular weight: Mw = 114 × 103 with a polydispersity of 2.5. Anal.
Calcd for C48H20F12N4O6: C, 59.03; H, 2.06; N, 5.74. Found: C, 58.54;
H, 2.04; N, 5.71.
6FDA-p-BOA (PIc). 1H NMR (300 MHz, DMSO-d6): δ 7.54 (br, s,
1H), 7.74 (br, s, 2H), 7.78 (br, s, 2H), 7.944 (s, 1H), 7.99 (m, 3H), 8.23
(br, s, 2H), 8.389 (br, s, 2H). ATR-FTIR (membrane, ν, cm−1): 1785
(imide CO symmetric stretching), 1719 (imide CO asymmetric
stretching), 1622, 1608 (cyclic CN/CC stretching), 1502, 1478
(skeletal vibrations in conjugated phenyl/benzoxazole ring), 1361
(imide −C−N), 1252 cm−1 (Ar−C−O asymmetric stretching).
Molecular weight: Mw = 115 × 103 with a polydispersity of 3.3. Anal.
Calcd for C32H13F6N3O5: C, 60.67; H, 2.07; N, 6.63. Found: C, 59.63;
H, 1.90; N, 6.45.
6FDA-m-BOA (PId). 1H NMR (300 MHz, DMSO-d6): δ 7.53 (br, s,
1H), 7.74−7.80 (m, 4H), 7.93−8.00 (m, 4H), 8.22−8.40 (m, 4H).
ATR-FTIR (membrane, ν, cm−1): 1785 (imide CO symmetric
stretching), 1720 (imide CO asymmetric stretching), 1625, 1610
(cyclic CN/CC stretching), 1492, 1477 (skeletal vibrations in
conjugated phenyl/benzoxazole ring), 1367 (imide −C−N), 1252 cm−1
(Ar−C−O asymmetric stretching). Molecular weight: Mw = 188 × 103
with a polydispersity of 2.9. Anal. Calcd for C32H13F6N3O5: C, 60.67; H,
2.07; N, 6.63. Found: C, 59.07; H, 1.72; N, 6.56.
Membrane Preparation. The poly(benzoxazole-co-imide) fibrous
powders were dissolved in NMP to form a 20 wt % polymer solution and
were cast onto clean glass plates after filtering with 1.0 μm Nylon (NY)
filter cartridges. The glass plates were placed in a vacuum oven and
slowly heated from 60 to 250 °C to evaporate solvent by successive
heating at 60, 100, 150, 200, and 250 °C for 1 h at each temperature. The
Synthesis of 5-Amino-2-(3-aminobenzene)benzoxazole (m-
BOA). The synthetic procedure was similar to that used for diamine p-
BFO except that 3-aminobenzoic acid and 2,4-diaminophenol
dihydrochloride were used as raw materials, respectively. The precipitate
was filtered off, rinsed with distilled water many times, recrystallized in
C
dx.doi.org/10.1021/ma501891m | Macromolecules XXXX, XXX, XXX−XXX